--Box Guides For FY 2025 EPS of $1.53-$1.57 on Revenue of $1.08-$1.085 Billion, vs CIQ Analyst Consensus of $1.70/Share on Revenue of $1.087 Billion-February 2024-www.financetom.com

--Box Guides For FY 2025 EPS of $1.53-$1.57 on Revenue of $1.08-$1.085 Billion, vs CIQ Analyst Consensus of $1.70/Share on Revenue of $1.087 Billion

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

--Box Guides For FY 2025 EPS of $1.53-$1.57 on Revenue of $1.08-$1.085 Billion, vs CIQ Analyst Consensus of $1.70/Share on Revenue of $1.087 Billion

Mar 5, 2024 1:22 PM

04:08 PM EST, 03/05/2024 (MT Newswires) --

Price: 27.25, Change: +0.02, Percent Change: +0.07

Previous page： C. H. Robinson Worldwide Insider Sold Shares Worth $803,120, According to a Recent SEC Filing Next page： Corcept Therapeutics Says New Drug Application for Cushing's Syndrome Treatment Filed by FDA

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

C. H. Robinson Worldwide Insider Sold Shares Worth $803,120, According to a Recent SEC Filing

Mar 3, 2025

05:26 PM EST, 03/03/2025 (MT Newswires) -- Angela K. Freeman, Chief Human Resources Officer and ESG Officer, on February 27, 2025, sold 8,000 shares in C. H. Robinson Worldwide (CHRW) for $803,120. Following the Form 4 filing with the SEC, Freeman has control over a total of 77,027 common shares of the company, with 77,027 shares held directly. SEC Filing:...

Corcept Therapeutics Says New Drug Application for Cushing's Syndrome Treatment Filed by FDA

Mar 3, 2025

05:29 PM EST, 03/03/2025 (MT Newswires) -- Corcept Therapeutics ( CORT ) said its new drug application for relacorilant to treat endogenous hypercortisolism, or Cushing's syndrome, was filed by the US Food and Drug Administration. The application is based on the results of trials showing positive results, the company said Monday in a statement. The FDA aims to complete its...

Green Dot Names Kim Olson Chief Risk Officer

Mar 3, 2025

05:31 PM EST, 03/03/2025 (MT Newswires) -- Green Dot ( GDOT ) said Monday it appointed Kim Olson as chief risk officer. Olson will oversee the company's risk management strategy and program execution while reporting directly to the chief executive. Most recently, Olson was head of the office of remediation at Discover Financial Services ( DFS ) , Green Dot...

Pan American Silver Says TSX Approves Renewal of Normal Course Issuer Bid

Mar 3, 2025

05:27 PM EST, 03/03/2025 (MT Newswires) -- Pan American Silver ( PAAS ) , after trade Monday, said the Toronto Stock Exchange approved the company's plan to renew its normal course issuer bid to buy back up to about 18.1 million of its shares, 5% of the total outstanding. The buyback will occur on the TSX, New York Stock Exchange,...